Skip to Main Content

Advertisement

Skip Nav Destination

Abstract LB-A21: Decouple the toxicity and efficacy of BJ-001, an integrin targeting IL-15

Mol Cancer Ther (2019) 18 (12_Supplement): LB-A21.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal